Skip to Main Content

Paper Details

Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.
Clin Gastroenterol Hepatol
3
2023
Author NameAffiliation
Parambir S DulaiNorthwestern University
Neeraj NarulaFarncombe Family Digestive Health Research Institute, McMaster University
  • 1 - 2

Datasets

Release 1.2